Literature DB >> 6685600

NADH and NADPH in human skeletal muscle at rest and during ischaemia.

K Sahlin.   

Abstract

A method for determining the content of NADH and NADPH in biopsy specimens from human skeletal muscle is described. It is based on the bioluminescent technique, utilizing oxidoreductases specific for NADH and NADPH, respectively. Muscle samples were taken from the lateral portion of the quadriceps muscle in the basal state and following local circulatory occlusion. In resting human skeletal muscle, the content of NADH was 91 +/- 6 mumol/kg dry muscle (mean +/- SE, n = 11) and the NAD/NADH ratio was 18.8 +/- 1.3. The content of NADPH determined in four subjects was 108 +/- 2 mumol/kg dry muscle. After 5 min of circulatory occlusion, NADH had risen about 100% and a further increase was found after 10 and 20 min, to a plateau about 150% above the basal value. The muscle content of NADPH also increased but to a minor extent (about 30% above the basal value). The changes in muscle lactate after 5 and 10 min occlusion were not uniform between subjects but an increase was obtained in all subjects after 20 min occlusion. No relation was found between the ratios pyruvate/lactate and NAD/NADH and the latter ratio was smaller than the estimated value, calculated from the LDH equilibrium in the cytoplasm. The results indicate that the major part of NADH in muscle tissue is confined to the mitochondrial compartment. It is concluded that measurement of NADH provides information primarily about the mitochondrial redox state rather than the cytosolic and that changes in NADH precede lactate formation and thus are a more sensitive index of tissue hypoxia than increases in lactate.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6685600     DOI: 10.1111/j.1475-097x.1983.tb00856.x

Source DB:  PubMed          Journal:  Clin Physiol        ISSN: 0144-5979


  13 in total

1.  In situ NADH laser fluorimetry during muscle contraction in humans.

Authors:  C Y Guezennec; F Lienhard; F Louisy; G Renault; M H Tusseau; P Portero
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

Review 2.  NAD(+)/NADH and skeletal muscle mitochondrial adaptations to exercise.

Authors:  Amanda T White; Simon Schenk
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-20       Impact factor: 4.310

3.  NADH content in type I and type II human muscle fibres after dynamic exercise.

Authors:  J M Ren; J Henriksson; A Katz; K Sahlin
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

4.  Repetitive static muscle contractions in humans--a trigger of metabolic and oxidative stress?

Authors:  K Sahlin; S Cizinsky; M Warholm; J Höberg
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

5.  Assessment of NAD+metabolism in human cell cultures, erythrocytes, cerebrospinal fluid and primate skeletal muscle.

Authors:  Tyler G Demarest; Gia Thinh D Truong; Jacqueline Lovett; Joy G Mohanty; Julie A Mattison; Mark P Mattson; Luigi Ferrucci; Vilhelm A Bohr; Ruin Moaddel
Journal:  Anal Biochem       Date:  2019-02-27       Impact factor: 3.365

6.  Redox state changes in human skeletal muscle after isometric contraction.

Authors:  J Henriksson; A Katz; K Sahlin
Journal:  J Physiol       Date:  1986-11       Impact factor: 5.182

Review 7.  Bang-bang model for regulation of local blood flow.

Authors:  Aleksander S Golub; Roland N Pittman
Journal:  Microcirculation       Date:  2013-08       Impact factor: 2.628

8.  High rates of extracellular superoxide generation by cultured human fibroblasts: involvement of a lipid-metabolizing enzyme.

Authors:  V B O'Donnell; A Azzi
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

9.  The content of NADH in rat skeletal muscle at rest and after cyanide poisoning.

Authors:  K Sahlin; A Katz
Journal:  Biochem J       Date:  1986-10-01       Impact factor: 3.857

10.  Redox state and lactate accumulation in human skeletal muscle during dynamic exercise.

Authors:  K Sahlin; A Katz; J Henriksson
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.